Global Pig Vaccine Market
Global Pig Vaccine Market

Pig Vaccine Comprehensive Study by Application (Veterinary Hospitals, Hog Production Farms), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines), Disease Indication (Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD), Others (CHRS, leptospirosis, etc.).) Players and Region - Global Market Outlook to 2025

Pig Vaccine Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Aug 2020 Edition 242 Pages 196 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Pig vaccines are medicinal products that protect pig from various viruses, bacteria, and pathogens. Pig vaccines contain antigens from viruses, bacteria or parasites that stimulate an immune response of pig which will protect pigs from natural infections. It also enhances overall productivity by protecting pigs and increases the production of high-quality meat for consumption. To control the transmission of diseases needs proper vaccination which help to improve the immunity of pigs.This growth is primarily driven by Growing Prevalence of Swine Diseases across the Globe and Rising Reproductive Failure and Growing Birth Rate of Weak Piglet.

Globally, a noticeable market trend is evident Technology Advancement in Vaccine Technology. Major Players, such as Merck Animal Health (United States), Boehringer Ingelheim (Germany), Jinyu Bio-technology (China), China Animal Husbandry (China), Zoetis (United States), Ceva (United States), HIPRA (Spain), Tianjin Ringpu (China), Brilliant Bio Pharma Private Limited (India), Aptimmune Biologics (United States) and Indian Immunologicals Ltd. (India) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Growing Prevalence of Swine Diseases across the Globe
  • Rising Reproductive Failure and Growing Birth Rate of Weak Piglet

Market Trend
  • Technology Advancement in Vaccine Technology

Restraints
  • High Expenses of Maintaining and Handling Storage Conditions

Opportunities
Rise in Investments by Governments in the field of Animal Health Care, Increasing R&D Expenses for New Vaccines and High Investments into vaccine development
Challenges
Chance of Reverse Reaction from Vaccines

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Veterinary Hospitals
  • Hog Production Farms
By Technology
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
  • DNA Vaccines

By Disease Indication
  • Diarrhea
  • Swine Influenza
  • Arthritis
  • Bordetella Rhinitis
  • Porcine Reproductive and Respiratory Syndrome (PRRS)
  • Porcine Circovirus Associated Disease (PCVAD)
  • Others (CHRS, leptospirosis, etc.).

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Swine Diseases across the Globe
      • 3.2.2. Rising Reproductive Failure and Growing Birth Rate of Weak Piglet
    • 3.3. Market Challenges
      • 3.3.1. Chance of Reverse Reaction from Vaccines
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Vaccine Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pig Vaccine, by Application, Technology, Disease Indication and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Pig Vaccine (Value)
      • 5.2.1. Global Pig Vaccine by: Application (Value)
        • 5.2.1.1. Veterinary Hospitals
        • 5.2.1.2. Hog Production Farms
      • 5.2.2. Global Pig Vaccine by: Technology (Value)
        • 5.2.2.1. Inactivated Vaccines
        • 5.2.2.2. Live Attenuated Vaccines
        • 5.2.2.3. Toxoid Vaccines
        • 5.2.2.4. Recombinant Vaccines
        • 5.2.2.5. Conjugate Vaccines
        • 5.2.2.6. DNA Vaccines
      • 5.2.3. Global Pig Vaccine by: Disease Indication (Value)
        • 5.2.3.1. Diarrhea
        • 5.2.3.2. Swine Influenza
        • 5.2.3.3. Arthritis
        • 5.2.3.4. Bordetella Rhinitis
        • 5.2.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
        • 5.2.3.6. Porcine Circovirus Associated Disease (PCVAD)
        • 5.2.3.7. Others (CHRS, leptospirosis, etc.).
      • 5.2.4. Global Pig Vaccine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pig Vaccine (Volume)
      • 5.3.1. Global Pig Vaccine by: Application (Volume)
        • 5.3.1.1. Veterinary Hospitals
        • 5.3.1.2. Hog Production Farms
      • 5.3.2. Global Pig Vaccine by: Technology (Volume)
        • 5.3.2.1. Inactivated Vaccines
        • 5.3.2.2. Live Attenuated Vaccines
        • 5.3.2.3. Toxoid Vaccines
        • 5.3.2.4. Recombinant Vaccines
        • 5.3.2.5. Conjugate Vaccines
        • 5.3.2.6. DNA Vaccines
      • 5.3.3. Global Pig Vaccine by: Disease Indication (Volume)
        • 5.3.3.1. Diarrhea
        • 5.3.3.2. Swine Influenza
        • 5.3.3.3. Arthritis
        • 5.3.3.4. Bordetella Rhinitis
        • 5.3.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
        • 5.3.3.6. Porcine Circovirus Associated Disease (PCVAD)
        • 5.3.3.7. Others (CHRS, leptospirosis, etc.).
      • 5.3.4. Global Pig Vaccine Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Pig Vaccine (Price)
  • 6. Pig Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck Animal Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boehringer Ingelheim (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Jinyu Bio-technology (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. China Animal Husbandry (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zoetis (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ceva (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. HIPRA (Spain)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Tianjin Ringpu (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Brilliant Bio Pharma Private Limited (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Aptimmune Biologics (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Indian Immunologicals Ltd. (India)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Pig Vaccine Sale, by Application, Technology, Disease Indication and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Pig Vaccine (Value)
      • 7.2.1. Global Pig Vaccine by: Application (Value)
        • 7.2.1.1. Veterinary Hospitals
        • 7.2.1.2. Hog Production Farms
      • 7.2.2. Global Pig Vaccine by: Technology (Value)
        • 7.2.2.1. Inactivated Vaccines
        • 7.2.2.2. Live Attenuated Vaccines
        • 7.2.2.3. Toxoid Vaccines
        • 7.2.2.4. Recombinant Vaccines
        • 7.2.2.5. Conjugate Vaccines
        • 7.2.2.6. DNA Vaccines
      • 7.2.3. Global Pig Vaccine by: Disease Indication (Value)
        • 7.2.3.1. Diarrhea
        • 7.2.3.2. Swine Influenza
        • 7.2.3.3. Arthritis
        • 7.2.3.4. Bordetella Rhinitis
        • 7.2.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
        • 7.2.3.6. Porcine Circovirus Associated Disease (PCVAD)
        • 7.2.3.7. Others (CHRS, leptospirosis, etc.).
      • 7.2.4. Global Pig Vaccine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pig Vaccine (Volume)
      • 7.3.1. Global Pig Vaccine by: Application (Volume)
        • 7.3.1.1. Veterinary Hospitals
        • 7.3.1.2. Hog Production Farms
      • 7.3.2. Global Pig Vaccine by: Technology (Volume)
        • 7.3.2.1. Inactivated Vaccines
        • 7.3.2.2. Live Attenuated Vaccines
        • 7.3.2.3. Toxoid Vaccines
        • 7.3.2.4. Recombinant Vaccines
        • 7.3.2.5. Conjugate Vaccines
        • 7.3.2.6. DNA Vaccines
      • 7.3.3. Global Pig Vaccine by: Disease Indication (Volume)
        • 7.3.3.1. Diarrhea
        • 7.3.3.2. Swine Influenza
        • 7.3.3.3. Arthritis
        • 7.3.3.4. Bordetella Rhinitis
        • 7.3.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS)
        • 7.3.3.6. Porcine Circovirus Associated Disease (PCVAD)
        • 7.3.3.7. Others (CHRS, leptospirosis, etc.).
      • 7.3.4. Global Pig Vaccine Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Pig Vaccine (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pig Vaccine: by Application(USD Million)
  • Table 2. Pig Vaccine Veterinary Hospitals , by Region USD Million (2014-2019)
  • Table 3. Pig Vaccine Hog Production Farms , by Region USD Million (2014-2019)
  • Table 4. Pig Vaccine: by Technology(USD Million)
  • Table 5. Pig Vaccine Inactivated Vaccines , by Region USD Million (2014-2019)
  • Table 6. Pig Vaccine Live Attenuated Vaccines , by Region USD Million (2014-2019)
  • Table 7. Pig Vaccine Toxoid Vaccines , by Region USD Million (2014-2019)
  • Table 8. Pig Vaccine Recombinant Vaccines , by Region USD Million (2014-2019)
  • Table 9. Pig Vaccine Conjugate Vaccines , by Region USD Million (2014-2019)
  • Table 10. Pig Vaccine DNA Vaccines , by Region USD Million (2014-2019)
  • Table 11. Pig Vaccine: by Disease Indication(USD Million)
  • Table 12. Pig Vaccine Diarrhea , by Region USD Million (2014-2019)
  • Table 13. Pig Vaccine Swine Influenza , by Region USD Million (2014-2019)
  • Table 14. Pig Vaccine Arthritis , by Region USD Million (2014-2019)
  • Table 15. Pig Vaccine Bordetella Rhinitis , by Region USD Million (2014-2019)
  • Table 16. Pig Vaccine Porcine Reproductive and Respiratory Syndrome (PRRS) , by Region USD Million (2014-2019)
  • Table 17. Pig Vaccine Porcine Circovirus Associated Disease (PCVAD) , by Region USD Million (2014-2019)
  • Table 18. Pig Vaccine Others (CHRS, leptospirosis, etc.). , by Region USD Million (2014-2019)
  • Table 19. South America Pig Vaccine, by Country USD Million (2014-2019)
  • Table 20. South America Pig Vaccine, by Application USD Million (2014-2019)
  • Table 21. South America Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 22. South America Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 23. Brazil Pig Vaccine, by Application USD Million (2014-2019)
  • Table 24. Brazil Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 25. Brazil Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 26. Argentina Pig Vaccine, by Application USD Million (2014-2019)
  • Table 27. Argentina Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 28. Argentina Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 29. Rest of South America Pig Vaccine, by Application USD Million (2014-2019)
  • Table 30. Rest of South America Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 31. Rest of South America Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 32. Asia Pacific Pig Vaccine, by Country USD Million (2014-2019)
  • Table 33. Asia Pacific Pig Vaccine, by Application USD Million (2014-2019)
  • Table 34. Asia Pacific Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 35. Asia Pacific Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 36. China Pig Vaccine, by Application USD Million (2014-2019)
  • Table 37. China Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 38. China Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 39. Japan Pig Vaccine, by Application USD Million (2014-2019)
  • Table 40. Japan Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 41. Japan Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 42. India Pig Vaccine, by Application USD Million (2014-2019)
  • Table 43. India Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 44. India Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 45. South Korea Pig Vaccine, by Application USD Million (2014-2019)
  • Table 46. South Korea Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 47. South Korea Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 48. Taiwan Pig Vaccine, by Application USD Million (2014-2019)
  • Table 49. Taiwan Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 50. Taiwan Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 51. Australia Pig Vaccine, by Application USD Million (2014-2019)
  • Table 52. Australia Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 53. Australia Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 54. Rest of Asia-Pacific Pig Vaccine, by Application USD Million (2014-2019)
  • Table 55. Rest of Asia-Pacific Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 56. Rest of Asia-Pacific Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 57. Europe Pig Vaccine, by Country USD Million (2014-2019)
  • Table 58. Europe Pig Vaccine, by Application USD Million (2014-2019)
  • Table 59. Europe Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 60. Europe Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 61. Germany Pig Vaccine, by Application USD Million (2014-2019)
  • Table 62. Germany Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 63. Germany Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 64. France Pig Vaccine, by Application USD Million (2014-2019)
  • Table 65. France Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 66. France Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 67. Italy Pig Vaccine, by Application USD Million (2014-2019)
  • Table 68. Italy Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 69. Italy Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 70. United Kingdom Pig Vaccine, by Application USD Million (2014-2019)
  • Table 71. United Kingdom Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 72. United Kingdom Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 73. Netherlands Pig Vaccine, by Application USD Million (2014-2019)
  • Table 74. Netherlands Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 75. Netherlands Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 76. Rest of Europe Pig Vaccine, by Application USD Million (2014-2019)
  • Table 77. Rest of Europe Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 78. Rest of Europe Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 79. MEA Pig Vaccine, by Country USD Million (2014-2019)
  • Table 80. MEA Pig Vaccine, by Application USD Million (2014-2019)
  • Table 81. MEA Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 82. MEA Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 83. Middle East Pig Vaccine, by Application USD Million (2014-2019)
  • Table 84. Middle East Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 85. Middle East Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 86. Africa Pig Vaccine, by Application USD Million (2014-2019)
  • Table 87. Africa Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 88. Africa Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 89. North America Pig Vaccine, by Country USD Million (2014-2019)
  • Table 90. North America Pig Vaccine, by Application USD Million (2014-2019)
  • Table 91. North America Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 92. North America Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 93. United States Pig Vaccine, by Application USD Million (2014-2019)
  • Table 94. United States Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 95. United States Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 96. Canada Pig Vaccine, by Application USD Million (2014-2019)
  • Table 97. Canada Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 98. Canada Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 99. Mexico Pig Vaccine, by Application USD Million (2014-2019)
  • Table 100. Mexico Pig Vaccine, by Technology USD Million (2014-2019)
  • Table 101. Mexico Pig Vaccine, by Disease Indication USD Million (2014-2019)
  • Table 102. Pig Vaccine Sales: by Application(Unit)
  • Table 103. Pig Vaccine Sales Veterinary Hospitals , by Region Unit (2014-2019)
  • Table 104. Pig Vaccine Sales Hog Production Farms , by Region Unit (2014-2019)
  • Table 105. Pig Vaccine Sales: by Technology(Unit)
  • Table 106. Pig Vaccine Sales Inactivated Vaccines , by Region Unit (2014-2019)
  • Table 107. Pig Vaccine Sales Live Attenuated Vaccines , by Region Unit (2014-2019)
  • Table 108. Pig Vaccine Sales Toxoid Vaccines , by Region Unit (2014-2019)
  • Table 109. Pig Vaccine Sales Recombinant Vaccines , by Region Unit (2014-2019)
  • Table 110. Pig Vaccine Sales Conjugate Vaccines , by Region Unit (2014-2019)
  • Table 111. Pig Vaccine Sales DNA Vaccines , by Region Unit (2014-2019)
  • Table 112. Pig Vaccine Sales: by Disease Indication(Unit)
  • Table 113. Pig Vaccine Sales Diarrhea , by Region Unit (2014-2019)
  • Table 114. Pig Vaccine Sales Swine Influenza , by Region Unit (2014-2019)
  • Table 115. Pig Vaccine Sales Arthritis , by Region Unit (2014-2019)
  • Table 116. Pig Vaccine Sales Bordetella Rhinitis , by Region Unit (2014-2019)
  • Table 117. Pig Vaccine Sales Porcine Reproductive and Respiratory Syndrome (PRRS) , by Region Unit (2014-2019)
  • Table 118. Pig Vaccine Sales Porcine Circovirus Associated Disease (PCVAD) , by Region Unit (2014-2019)
  • Table 119. Pig Vaccine Sales Others (CHRS, leptospirosis, etc.). , by Region Unit (2014-2019)
  • Table 120. South America Pig Vaccine Sales, by Country Unit (2014-2019)
  • Table 121. South America Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 122. South America Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 123. South America Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 124. Brazil Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 125. Brazil Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 126. Brazil Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 127. Argentina Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 128. Argentina Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 129. Argentina Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 130. Rest of South America Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 131. Rest of South America Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 132. Rest of South America Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 133. Asia Pacific Pig Vaccine Sales, by Country Unit (2014-2019)
  • Table 134. Asia Pacific Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 135. Asia Pacific Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 136. Asia Pacific Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 137. China Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 138. China Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 139. China Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 140. Japan Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 141. Japan Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 142. Japan Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 143. India Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 144. India Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 145. India Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 146. South Korea Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 147. South Korea Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 148. South Korea Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 149. Taiwan Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 150. Taiwan Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 151. Taiwan Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 152. Australia Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 153. Australia Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 154. Australia Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 155. Rest of Asia-Pacific Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 156. Rest of Asia-Pacific Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 157. Rest of Asia-Pacific Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 158. Europe Pig Vaccine Sales, by Country Unit (2014-2019)
  • Table 159. Europe Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 160. Europe Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 161. Europe Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 162. Germany Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 163. Germany Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 164. Germany Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 165. France Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 166. France Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 167. France Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 168. Italy Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 169. Italy Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 170. Italy Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 171. United Kingdom Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 172. United Kingdom Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 173. United Kingdom Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 174. Netherlands Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 175. Netherlands Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 176. Netherlands Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 177. Rest of Europe Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 178. Rest of Europe Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 179. Rest of Europe Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 180. MEA Pig Vaccine Sales, by Country Unit (2014-2019)
  • Table 181. MEA Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 182. MEA Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 183. MEA Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 184. Middle East Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 185. Middle East Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 186. Middle East Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 187. Africa Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 188. Africa Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 189. Africa Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 190. North America Pig Vaccine Sales, by Country Unit (2014-2019)
  • Table 191. North America Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 192. North America Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 193. North America Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 194. United States Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 195. United States Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 196. United States Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 197. Canada Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 198. Canada Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 199. Canada Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 200. Mexico Pig Vaccine Sales, by Application Unit (2014-2019)
  • Table 201. Mexico Pig Vaccine Sales, by Technology Unit (2014-2019)
  • Table 202. Mexico Pig Vaccine Sales, by Disease Indication Unit (2014-2019)
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Pig Vaccine: by Application(USD Million)
  • Table 215. Pig Vaccine Veterinary Hospitals , by Region USD Million (2020-2025)
  • Table 216. Pig Vaccine Hog Production Farms , by Region USD Million (2020-2025)
  • Table 217. Pig Vaccine: by Technology(USD Million)
  • Table 218. Pig Vaccine Inactivated Vaccines , by Region USD Million (2020-2025)
  • Table 219. Pig Vaccine Live Attenuated Vaccines , by Region USD Million (2020-2025)
  • Table 220. Pig Vaccine Toxoid Vaccines , by Region USD Million (2020-2025)
  • Table 221. Pig Vaccine Recombinant Vaccines , by Region USD Million (2020-2025)
  • Table 222. Pig Vaccine Conjugate Vaccines , by Region USD Million (2020-2025)
  • Table 223. Pig Vaccine DNA Vaccines , by Region USD Million (2020-2025)
  • Table 224. Pig Vaccine: by Disease Indication(USD Million)
  • Table 225. Pig Vaccine Diarrhea , by Region USD Million (2020-2025)
  • Table 226. Pig Vaccine Swine Influenza , by Region USD Million (2020-2025)
  • Table 227. Pig Vaccine Arthritis , by Region USD Million (2020-2025)
  • Table 228. Pig Vaccine Bordetella Rhinitis , by Region USD Million (2020-2025)
  • Table 229. Pig Vaccine Porcine Reproductive and Respiratory Syndrome (PRRS) , by Region USD Million (2020-2025)
  • Table 230. Pig Vaccine Porcine Circovirus Associated Disease (PCVAD) , by Region USD Million (2020-2025)
  • Table 231. Pig Vaccine Others (CHRS, leptospirosis, etc.). , by Region USD Million (2020-2025)
  • Table 232. South America Pig Vaccine, by Country USD Million (2020-2025)
  • Table 233. South America Pig Vaccine, by Application USD Million (2020-2025)
  • Table 234. South America Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 235. South America Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 236. Brazil Pig Vaccine, by Application USD Million (2020-2025)
  • Table 237. Brazil Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 238. Brazil Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 239. Argentina Pig Vaccine, by Application USD Million (2020-2025)
  • Table 240. Argentina Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 241. Argentina Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 242. Rest of South America Pig Vaccine, by Application USD Million (2020-2025)
  • Table 243. Rest of South America Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 244. Rest of South America Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 245. Asia Pacific Pig Vaccine, by Country USD Million (2020-2025)
  • Table 246. Asia Pacific Pig Vaccine, by Application USD Million (2020-2025)
  • Table 247. Asia Pacific Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 248. Asia Pacific Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 249. China Pig Vaccine, by Application USD Million (2020-2025)
  • Table 250. China Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 251. China Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 252. Japan Pig Vaccine, by Application USD Million (2020-2025)
  • Table 253. Japan Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 254. Japan Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 255. India Pig Vaccine, by Application USD Million (2020-2025)
  • Table 256. India Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 257. India Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 258. South Korea Pig Vaccine, by Application USD Million (2020-2025)
  • Table 259. South Korea Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 260. South Korea Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 261. Taiwan Pig Vaccine, by Application USD Million (2020-2025)
  • Table 262. Taiwan Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 263. Taiwan Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 264. Australia Pig Vaccine, by Application USD Million (2020-2025)
  • Table 265. Australia Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 266. Australia Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 267. Rest of Asia-Pacific Pig Vaccine, by Application USD Million (2020-2025)
  • Table 268. Rest of Asia-Pacific Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 269. Rest of Asia-Pacific Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 270. Europe Pig Vaccine, by Country USD Million (2020-2025)
  • Table 271. Europe Pig Vaccine, by Application USD Million (2020-2025)
  • Table 272. Europe Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 273. Europe Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 274. Germany Pig Vaccine, by Application USD Million (2020-2025)
  • Table 275. Germany Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 276. Germany Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 277. France Pig Vaccine, by Application USD Million (2020-2025)
  • Table 278. France Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 279. France Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 280. Italy Pig Vaccine, by Application USD Million (2020-2025)
  • Table 281. Italy Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 282. Italy Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 283. United Kingdom Pig Vaccine, by Application USD Million (2020-2025)
  • Table 284. United Kingdom Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 285. United Kingdom Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 286. Netherlands Pig Vaccine, by Application USD Million (2020-2025)
  • Table 287. Netherlands Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 288. Netherlands Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 289. Rest of Europe Pig Vaccine, by Application USD Million (2020-2025)
  • Table 290. Rest of Europe Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 291. Rest of Europe Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 292. MEA Pig Vaccine, by Country USD Million (2020-2025)
  • Table 293. MEA Pig Vaccine, by Application USD Million (2020-2025)
  • Table 294. MEA Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 295. MEA Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 296. Middle East Pig Vaccine, by Application USD Million (2020-2025)
  • Table 297. Middle East Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 298. Middle East Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 299. Africa Pig Vaccine, by Application USD Million (2020-2025)
  • Table 300. Africa Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 301. Africa Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 302. North America Pig Vaccine, by Country USD Million (2020-2025)
  • Table 303. North America Pig Vaccine, by Application USD Million (2020-2025)
  • Table 304. North America Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 305. North America Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 306. United States Pig Vaccine, by Application USD Million (2020-2025)
  • Table 307. United States Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 308. United States Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 309. Canada Pig Vaccine, by Application USD Million (2020-2025)
  • Table 310. Canada Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 311. Canada Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 312. Mexico Pig Vaccine, by Application USD Million (2020-2025)
  • Table 313. Mexico Pig Vaccine, by Technology USD Million (2020-2025)
  • Table 314. Mexico Pig Vaccine, by Disease Indication USD Million (2020-2025)
  • Table 315. Pig Vaccine Sales: by Application(Unit)
  • Table 316. Pig Vaccine Sales Veterinary Hospitals , by Region Unit (2020-2025)
  • Table 317. Pig Vaccine Sales Hog Production Farms , by Region Unit (2020-2025)
  • Table 318. Pig Vaccine Sales: by Technology(Unit)
  • Table 319. Pig Vaccine Sales Inactivated Vaccines , by Region Unit (2020-2025)
  • Table 320. Pig Vaccine Sales Live Attenuated Vaccines , by Region Unit (2020-2025)
  • Table 321. Pig Vaccine Sales Toxoid Vaccines , by Region Unit (2020-2025)
  • Table 322. Pig Vaccine Sales Recombinant Vaccines , by Region Unit (2020-2025)
  • Table 323. Pig Vaccine Sales Conjugate Vaccines , by Region Unit (2020-2025)
  • Table 324. Pig Vaccine Sales DNA Vaccines , by Region Unit (2020-2025)
  • Table 325. Pig Vaccine Sales: by Disease Indication(Unit)
  • Table 326. Pig Vaccine Sales Diarrhea , by Region Unit (2020-2025)
  • Table 327. Pig Vaccine Sales Swine Influenza , by Region Unit (2020-2025)
  • Table 328. Pig Vaccine Sales Arthritis , by Region Unit (2020-2025)
  • Table 329. Pig Vaccine Sales Bordetella Rhinitis , by Region Unit (2020-2025)
  • Table 330. Pig Vaccine Sales Porcine Reproductive and Respiratory Syndrome (PRRS) , by Region Unit (2020-2025)
  • Table 331. Pig Vaccine Sales Porcine Circovirus Associated Disease (PCVAD) , by Region Unit (2020-2025)
  • Table 332. Pig Vaccine Sales Others (CHRS, leptospirosis, etc.). , by Region Unit (2020-2025)
  • Table 333. South America Pig Vaccine Sales, by Country Unit (2020-2025)
  • Table 334. South America Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 335. South America Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 336. South America Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 337. Brazil Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 338. Brazil Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 339. Brazil Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 340. Argentina Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 341. Argentina Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 342. Argentina Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 343. Rest of South America Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 344. Rest of South America Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 345. Rest of South America Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 346. Asia Pacific Pig Vaccine Sales, by Country Unit (2020-2025)
  • Table 347. Asia Pacific Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 348. Asia Pacific Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 349. Asia Pacific Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 350. China Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 351. China Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 352. China Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 353. Japan Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 354. Japan Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 355. Japan Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 356. India Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 357. India Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 358. India Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 359. South Korea Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 360. South Korea Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 361. South Korea Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 362. Taiwan Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 363. Taiwan Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 364. Taiwan Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 365. Australia Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 366. Australia Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 367. Australia Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 368. Rest of Asia-Pacific Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 369. Rest of Asia-Pacific Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 370. Rest of Asia-Pacific Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 371. Europe Pig Vaccine Sales, by Country Unit (2020-2025)
  • Table 372. Europe Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 373. Europe Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 374. Europe Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 375. Germany Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 376. Germany Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 377. Germany Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 378. France Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 379. France Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 380. France Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 381. Italy Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 382. Italy Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 383. Italy Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 384. United Kingdom Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 385. United Kingdom Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 386. United Kingdom Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 387. Netherlands Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 388. Netherlands Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 389. Netherlands Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 390. Rest of Europe Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 391. Rest of Europe Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 392. Rest of Europe Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 393. MEA Pig Vaccine Sales, by Country Unit (2020-2025)
  • Table 394. MEA Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 395. MEA Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 396. MEA Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 397. Middle East Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 398. Middle East Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 399. Middle East Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 400. Africa Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 401. Africa Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 402. Africa Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 403. North America Pig Vaccine Sales, by Country Unit (2020-2025)
  • Table 404. North America Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 405. North America Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 406. North America Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 407. United States Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 408. United States Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 409. United States Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 410. Canada Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 411. Canada Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 412. Canada Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 413. Mexico Pig Vaccine Sales, by Application Unit (2020-2025)
  • Table 414. Mexico Pig Vaccine Sales, by Technology Unit (2020-2025)
  • Table 415. Mexico Pig Vaccine Sales, by Disease Indication Unit (2020-2025)
  • Table 416. Research Programs/Design for This Report
  • Table 417. Key Data Information from Secondary Sources
  • Table 418. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pig Vaccine: by Application USD Million (2014-2019)
  • Figure 5. Global Pig Vaccine: by Technology USD Million (2014-2019)
  • Figure 6. Global Pig Vaccine: by Disease Indication USD Million (2014-2019)
  • Figure 7. South America Pig Vaccine Share (%), by Country
  • Figure 8. Asia Pacific Pig Vaccine Share (%), by Country
  • Figure 9. Europe Pig Vaccine Share (%), by Country
  • Figure 10. MEA Pig Vaccine Share (%), by Country
  • Figure 11. North America Pig Vaccine Share (%), by Country
  • Figure 12. Global Pig Vaccine: by Application Unit (2014-2019)
  • Figure 13. Global Pig Vaccine: by Technology Unit (2014-2019)
  • Figure 14. Global Pig Vaccine: by Disease Indication Unit (2014-2019)
  • Figure 15. South America Pig Vaccine Share (%), by Country
  • Figure 16. Asia Pacific Pig Vaccine Share (%), by Country
  • Figure 17. Europe Pig Vaccine Share (%), by Country
  • Figure 18. MEA Pig Vaccine Share (%), by Country
  • Figure 19. North America Pig Vaccine Share (%), by Country
  • Figure 20. Global Pig Vaccine share by Players 2019 (%)
  • Figure 21. Global Pig Vaccine share by Players (Top 3) 2019(%)
  • Figure 22. Global Pig Vaccine share by Players (Top 5) 2019(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Merck Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck Animal Health (United States) Revenue: by Geography 2019
  • Figure 26. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Boehringer Ingelheim (Germany) Revenue: by Geography 2019
  • Figure 28. Jinyu Bio-technology (China) Revenue, Net Income and Gross profit
  • Figure 29. Jinyu Bio-technology (China) Revenue: by Geography 2019
  • Figure 30. China Animal Husbandry (China) Revenue, Net Income and Gross profit
  • Figure 31. China Animal Husbandry (China) Revenue: by Geography 2019
  • Figure 32. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 33. Zoetis (United States) Revenue: by Geography 2019
  • Figure 34. Ceva (United States) Revenue, Net Income and Gross profit
  • Figure 35. Ceva (United States) Revenue: by Geography 2019
  • Figure 36. HIPRA (Spain) Revenue, Net Income and Gross profit
  • Figure 37. HIPRA (Spain) Revenue: by Geography 2019
  • Figure 38. Tianjin Ringpu (China) Revenue, Net Income and Gross profit
  • Figure 39. Tianjin Ringpu (China) Revenue: by Geography 2019
  • Figure 40. Brilliant Bio Pharma Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 41. Brilliant Bio Pharma Private Limited (India) Revenue: by Geography 2019
  • Figure 42. Aptimmune Biologics (United States) Revenue, Net Income and Gross profit
  • Figure 43. Aptimmune Biologics (United States) Revenue: by Geography 2019
  • Figure 44. Indian Immunologicals Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 45. Indian Immunologicals Ltd. (India) Revenue: by Geography 2019
  • Figure 46. Global Pig Vaccine: by Application USD Million (2020-2025)
  • Figure 47. Global Pig Vaccine: by Technology USD Million (2020-2025)
  • Figure 48. Global Pig Vaccine: by Disease Indication USD Million (2020-2025)
  • Figure 49. South America Pig Vaccine Share (%), by Country
  • Figure 50. Asia Pacific Pig Vaccine Share (%), by Country
  • Figure 51. Europe Pig Vaccine Share (%), by Country
  • Figure 52. MEA Pig Vaccine Share (%), by Country
  • Figure 53. North America Pig Vaccine Share (%), by Country
  • Figure 54. Global Pig Vaccine: by Application Unit (2020-2025)
  • Figure 55. Global Pig Vaccine: by Technology Unit (2020-2025)
  • Figure 56. Global Pig Vaccine: by Disease Indication Unit (2020-2025)
  • Figure 57. South America Pig Vaccine Share (%), by Country
  • Figure 58. Asia Pacific Pig Vaccine Share (%), by Country
  • Figure 59. Europe Pig Vaccine Share (%), by Country
  • Figure 60. MEA Pig Vaccine Share (%), by Country
  • Figure 61. North America Pig Vaccine Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Merck Animal Health (United States)
  • Boehringer Ingelheim (Germany)
  • Jinyu Bio-technology (China)
  • China Animal Husbandry (China)
  • Zoetis (United States)
  • Ceva (United States)
  • HIPRA (Spain)
  • Tianjin Ringpu (China)
  • Brilliant Bio Pharma Private Limited (India)
  • Aptimmune Biologics (United States)
  • Indian Immunologicals Ltd. (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation